Earnings History Data for Graybug Vision, Inc. (GRAY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Graybug Vision, Inc.

Graybug Vision Inc. is a clinical-stage biopharmaceutical company. It is focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve. The company's product candidate includes GB-102, GB-401 and GB-103 which are in clinical stage. Graybug Vision Inc. is headquartered in Redwood City, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-08-2022 PM GRAY Graybug Vision, Inc. 21.02 -0.38 -0.38 -0.36 Graybug Vision GAAP EPS of -$0.38 beats by $0.02
[8/11/2022 9:02 AM]
3.76 -0.21 
(-5.29%)
1.02 0.01 
(0.99%)
3.68 - 12.42 14,481 20,000 16,368
10-05-2022 AH GRAY Graybug Vision, Inc. 17.30 -0.48 -0.34 -0.54 Graybug Vision GAAP EPS of -$0.48
[5/10/2022 5:27 PM]
0.76 -0.06 
(-6.75%)
0.82 0.01 
(0.61%)
0.73 - 7.06 20,681 50,000 300
12-05-2021 PM GRAY Graybug Vision, Inc. 90.00 -0.54 -0.45 0.00 Graybug Vision EPS misses by $0.08
[5/12/2021 7:47 AM]
4.11 -0.62 
(-13.11%)
4.35 -0.38 
(-8.03%)
3.95 - 37.88 1,282,922 690,000 389,616